Our Pipeline

Isosceles is developing a number of proprietary parenteral delivery options with a potentially better safety profile when compared to oral dose formulations. Our novel delivery approaches are designed to offer the patient improved analgesia by maximizing systemic delivery while avoiding side effects from first pass exposure.

---

For more information about our pipeline please contact us using the button below.
Contact Us